from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2548/vapC19

LFCtreatmentdescriptionclass of inhibitor

0.674

Amikacinug/mL Amikacintranslation

-0.355

Cap5-10ug/mL Capreomycintranslation

-0.761

Rox10-50 ug/mL Roxithromycintranslation

0.388

SM2-5 ug/mL Streptomycintranslation

1.955

Tet5-10 ug/mL Tetracyclinetranslation

0.859

Rif0.2-5ug/mL Rifampicintranscription

0.024

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.265

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.811

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.053

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.280

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.329

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.237

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.613

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.251

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.197

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.146

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.332

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.151

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.104

KCN5-20 ug/mL Potassium cyaniderespiration

-0.206

NaN30.2-2 mM Sodium aziderespiration

-0.931

Nigericin50 uM Nigericinrespiration

0.264

TRC10-150 ug/mL Triclosanrespiration

-0.783

TRZ10-25 ug/mL Thioridazinerespiration

0.619

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.200

menadione6-10 ug/mL Menadionerespiration

0.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.322

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.947

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.007

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.447

NRP_1Non-replicating persistence stage 1dosRassociated

0.653

Amp0.2mg/mL AmpicillincellWall

-0.459

Cephalexin20-100 ug/mL CephalexincellWall

0.361

Cerulenin0.32-5 ug/mL CerulenincellWall

0.915

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.283

EMB10-20 ug/mL EthambutolcellWall

0.118

Eta12-40 ug/mL EthionamidecellWall

-0.123

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.178

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.382

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.453

BZA0.12 mg/mL BenzamidearomaticAmides

-0.568

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.205

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.258

H2O24 mM hydrogen peroxideDNAdamaging

-0.164

Levo10 ug/mL LevofloxacinDNAdamaging

-0.551

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.729

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.907

UVUV-irradiationDNAdamaging

0.357

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.530

Antimycin12.5-50 ug/mL Antimycin A?

0.103

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.297

PA_110-50 ug/mL Antitubercular compound PA-1?

0.018

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.005

PA8240.2-2 ug/mL PA-824?

-0.279

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.291

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.091

Verapamil50 uM Verapamil?

0.316

mercaptoethanol2 mM 2-Mercaptoethanol?

0.214

methoxatin10-20 ug/mL Methoxatin?